science1 distinct publisher
An oral GLP-1 moves the bottleneck from the cold chain to the prescription pad
Orforglipron's approval takes peptide manufacturing and refrigeration off the constraint list. What replaces them is prescribing capacity in primary care and daily adherence.
Publishers:discovermagazine.com
Reality
- Evidence42
- Adoption48
- Hype gap+28
- Incentives58
- Confidence40